Document is current

Any future updates will be listed below

Combination antiemetic therapy with aprepitant/fosaprepitant in patients with colorectal cancer receiving oxaliplatin-based chemotherapy in the SENRI trial: analysis of risk factors for vomiting and nausea

Crossref DOI link: https://doi.org/10.1007/s10147-016-1022-9

Published Online: 2016-07-27

Published Print: 2017-02

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark